Osteopore (ASX:OSX) Cash Receipts from Operating Activities: A$ Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Osteopore Cash Receipts from Operating Activities?

Osteopore ASX:OSX Cash Receipts from Operating Activities is A$ Mil as of Jun. 2026. The stock has 7 warning signs investors should review.

Osteopore's Cash Receipts from Operating Activities for the six months ended in Jun. 2026 was A$ Mil.

Osteopore's Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Jun. 2026 was A$ Mil.

Osteopore Cash Receipts from Operating Activities Related Terms

Osteopore Cash Receipts from Operating Activities Historical Data

* Premium members only.

The historical data trend for Osteopore's Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Osteopore Cash Receipts from Operating Activities Chart

Osteopore Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Receipts from Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Osteopore Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cash Receipts from Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Osteopore Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Receipts from Operating Activities of A$ Mil mean?
Osteopore (ASX:OSX) has a Cash Receipts from Operating Activities of A$ Mil as of Jun. 2026. Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method. View historical data for Osteopore and its competitors.
Is Osteopore's Cash Receipts from Operating Activities too high?
Osteopore's current Cash Receipts from Operating Activities is A$ Mil.
How does Osteopore's Cash Receipts from Operating Activities compare to ISRG and BDX?
Osteopore's Cash Receipts from Operating Activities of A$ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Receipts from Operating Activities for a Medical Devices & Instruments company?
A good Cash Receipts from Operating Activities depends on the Medical Devices & Instruments industry context. However, Cash Receipts from Operating Activities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Receipts from Operating Activities mean?
A high Cash Receipts from Operating Activities can signal that a stock is expensive relative to its fundamentals. Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method. View historical data for Osteopore and its competitors. Osteopore's current Cash Receipts from Operating Activities is A$ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osteopore stock overvalued right now?
Based on GuruFocus' analysis, Osteopore (ASX:OSX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.01, compared to a current price of A$0.00 — trading 70% below its estimated fair value. The current Cash Receipts from Operating Activities is A$ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Receipts from Operating Activities calculated?
Cash Receipts from Operating Activities is calculated from a company's financial statements. For Osteopore (ASX:OSX), the current Cash Receipts from Operating Activities is A$ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Osteopore Business Description

Address 2 Tukang Innovation Grove, No. 09-06 and 07, JTC MedTech Hub, Singapore, SGP, 618305
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. It operate in the high-growth regenerative medicine sector, where adoption continues to rise as healthcare systems increasingly embrace developed tissue-regenerative solutions. Business operating segments are based on the firm's geographical presence in Singapore and Australia.